コンテンツにジャンプ
国立がん研究センター 東病院

トップページ > 診療科のご案内 > 呼吸器外科 > 業績

業績

2016年

  1. Saruwatari K, Ikemura S, Sekihara K, Kuwata T, Fujii S, Umemura S, Kirita K, Matsumoto S, Yoh K, Niho S, Ohmatsu H, Ochiai A, Kohrogi H, Tsuboi M, Goto K, Ishii G. Aggressive tumor microenvironment of solid predominant lung adenocarcinoma subtype harboring with epidermal growth factor receptor mutations. Lung Cancer, 91:7-14, 2016.1
  2. Hisakane K, Saruwatari K, Fujii S, Kirita K, Umemura S, Matsumoto S, Yoh K, Niho S, Ohmatsu H, Kuwata T, Ochiai A, Gemma A, Tsuboi M, Goto K, Ishii G. Unique intravascular tumor microenvironment predicting recurrence of lung squamous cell carcinoma. J Cancer Res Clin Oncol, 142(3):593-600, 2016.3
  3. Hishida T, Yoshida J, Aokage K, Nagai K, Tsuboi M. Postoperative oligo-recurrence of non-small-cell lung cancer: clinical features and survival†. Eur J Cardiothorac Surg, 49(3):847-53, 2016.3
  4. Matsuzawa R, Kirita K, Kuwata T, Umemura S, Matsumoto S, Fujii S, Yoh K, Kojima M, Niho S, Ohmatsu H, Ochiai A, Tsuboi M, Goto K, Ishii G. Factors influencing the concordance of histological subtype diagnosis from biopsy and resected specimens of lung adenocarcinoma. Lung Cancer, 94:1-6, 2016.4
  5. Watanabe K, Tsuboi M, Sakamaki K, Nishii T, Yamamoto T, Nagashima T, Ando K, Ishikawa Y, Woo T, Adachi H, Kumakiri Y, Maehara T, Nakayama H, Masuda M. Postoperative follow-up strategy based on recurrence dynamics for non-small-cell lung cancer†. Eur J Cardiothorac Surg, 49(6):1624-31. 2016.6
  6. Mimae T, Suzuki K, Tsuboi M, Ikeda N, Takamochi K, Aokage K, Shimada Y, Miyata Y, Okada M. Severity of lung fibrosis affects early surgical outcomes of lung cancer among patients with combined pulmonary fibrosis and emphysema. Medicine (Baltimore), 95(29):e4314, 2016.7
  7. Suda Y, Neri S, Hashimoto H, Higuchi Y, Ishibashi M, Sugano M, Masutomi K, Tsuboi M, Ochiai A, Ishii G. Clonal heterogeneity in osteogenic potential of lung cancer-associated fibroblasts: promotional effect of osteogenic progenitor cells on cancer cell migration. J Cancer Res Clin Oncol, 142(7):1487-98. 2016.7
  8. Zenke Y, Umemura S, Motegi A, Furukawa K, Kirita K, Matsumoto S, Yoh K, Niho S, Ohmatsu H, Tsuboi M, Akimoto T, Goto K. Acute and progressive tracheal stenosis after proton beam therapy with concurrent chemotherapy for non-small cell lung cancer. J Thorac Oncol, 11(7):1181-3. 2016.7
  9. Iwata T, Yoshino I, Yoshida S, Ikeda N, Tsuboi M, Asato Y, Katakami N, Sakamoto K, Yamashita Y, Okami J, Mitsudomi T, Yamashita M, Yokouchi H, Okubo K, Okada M, Takenoyama M, Chida M, Tomii K, Matsuura M, Azuma A, Iwasawa T, Kuwano K, Sakai S, Hiroshima K, Fukuoka J, Yoshimura K, Tada H, Nakagawa K, Nakanishi Y; West Japan Oncology Group. A phase II trial evaluating the efficacy and safety of perioperative pirfenidone for prevention of acute exacerbation of idiopathic pulmonary fibrosis in lung cancer patients undergoing pulmonary resection: West Japan Oncology Group 6711 L (PEOPLE Study). Respir Res, 22;17(1):90, 2016.7
  10. Hishida T, Yoshida J, Aokage K, Nagai K, Tsuboi M. Long-term outcome of surgical resection for residual or regrown advanced non-small cell lung carcinomas following EGFR-TKI treatment: report of four cases. Gen Thorac Cardiovasc Surg, 64(7):429-33, 2016.7
  11. Shiraishi K, Okada Y, Takahashi A, Kamatani Y, Momozawa Y, Ashikawa K, Kunitoh H, Matsumoto S, Takano A, Shimizu K, Goto A, Tsuta K, Watanabe S, Ohe Y, Watanabe Y, Goto Y, Nokihara H, Furuta K, Yoshida A, Goto K, Hishida T, Tsuboi M, Tsuchihara K, Miyagi Y, Nakayama H, Yokose T, Tanaka K, Nagashima T, Ohtaki Y, Maeda D, Imai K, Minamiya Y, Sakamoto H, Saito A, Shimada Y, Sunami K, Saito M, Inazawa J, Nakamura Y, Yoshida T, Yokota J, Matsuda F, Matsuo K, Daigo Y, Kubo M, Kohno T. Association of variations in HLA class II and other loci with susceptibility to EGFR-mutated lung adenocarcinoma. Nat Commun. 9;7:12451, 2016.8
  12. Hishida T, Miyaoka E, Yokoi K, Tsuboi M, Asamura H, Kiura K, Takahashi K, Dosaka-Akita H, Kobayashi H, Date H, Tada H, Okumura M, Yoshino I; Japanese Joint Committee of Lung Cancer Registry. Lobe-Specific Nodal Dissection for Clinical Stage I and II NSCLC: Japanese Multi-Institutional Retrospective Study Using a Propensity Score Analysis. J Thorac Oncol, 11(9):1529-37. 2016.9
  13. Nishio W, Yoshimura M, Maniwa Y, Kitamura Y, Tane K, Takenaka D, Adachi S.  Re-Assessment of Intentional Extended Segmentectomy for Clinical T1aN0 Non-Small Cell Lung Cancer.  Ann Thorac Surg. 102(5):1702-1710. 2016.11
  14. 池村辰之介、坪井正博. 非小細胞肺癌の術後化学療法の適応について、患者側因子がどう影響するか? EBM呼吸器疾患の治療2016-2017. 396-403. 2016
  15. 石橋昌幸、桐田圭輔、青景圭樹、松本慎吾、梅村茂樹、仁保誠治、大松広伸、坪井正博、後藤功一. 多発気管・気管支内転移を伴う再発肺扁平上皮癌に対して複数回の光線力学療法で気道開存維持を得た1例. 気管支学. 第38巻 第5号 2016年9月
  16. 菱田智之、坪井正博. 大腸癌肺転移切除後の予後と予後因子. 日本臨床. 第74巻 第11号 1842-1846. 2016
  17. 監修:坪井正博、発行者:穂谷竹俊. 図解 肺がんの最新治療と予防&生活対策  日東書院 2016年3月.